LL
Lawley Lori D
Chief Financial Officer
OtherF
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Lawley Lori D, Chief Financial Officer. Officer active across 2 companies, notably LUMOS PHARMA, INC.. Aggregated, 11 filings have been published. History available since 1 August 2021. The latest transaction was disclosed on 1 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lawley Lori D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
12,284 sharesCommon StockSEC:0001126234-24-000112:0
229 shares@ US$1.791.8% of flowCommon StockSEC:0001126234-24-000092:0
1,000 shares@ US$2.8412.4% of flowCommon StockSEC:0001126234-24-000038:0
215 shares@ US$3.012.8% of flowCommon StockSEC:0001126234-24-000014:0
229 shares@ US$3.283.2% of flowCommon StockSEC:0001126234-23-000084:0
274 shares@ US$3.313.9% of flowCommon StockSEC:0001126234-23-000050:0
1,000 shares@ US$3.5215.1% of flowCommon StockSEC:0001126234-23-000015:0
229 shares@ US$8.178.5% of flowCommon StockSEC:0001126234-22-000071:0
274 shares@ US$9.2310.7% of flowCommon StockSEC:0001126234-22-000033:0
1,000 shares@ US$10.0241.7% of flowCommon StockSEC:0001126234-22-000009:0
3,750 shares0Common StockSEC:0001126234-21-000101:0
About Lawley Lori D
Lawley Lori D is Directeur Financier at Lumos Pharma, INC. on XNAS. She has 11 filings, and the sampled recent filings cover the period from 2021-08-03 to 2024-12-13, with transaction nature indicated as tax withholding.